
Standard retreatment for relapsed hairy cell leukemia often involves cumulative chemotherapy toxicity, prompting the search for alternative therapies that do not carry the risk of graft-versus-host disease. Recent advancements in hematologic oncology have ushered in a new era of precision medicine,
FDA released final guidance Monday explaining how developers of cell-based and gene-based treatments should demonstrate potency, meaning the biological activity a treatment needs to have its intended effect. Developers should start checking potency early during development and keep checking as
By bridging the gap between cellular transcription and secretion, the Cascade initiative provides the stimulus-specific data required for high-fidelity AI simulations. For decades, the pharmaceutical industry has struggled with the fragmented nature of biological data, often relying on disparate
Incyte Corporation and Genmab A/S have joined forces to launch a Phase 1/2 clinical trial aimed at transforming the treatment landscape for metastatic colorectal cancer patients with the KRAS G12D mutation. This specific genetic alteration has long served as a formidable barrier in oncology, as it
Aspen Neuroscience’s sasineprocel starts with cells collected from a patient’s skin and aims to rebuild a population of neurons lost in Parkinson’s disease. To advance clinical testing, the company has raised $140.6 million through an initial public offering. The program now has to answer a central
The sheer complexity of microbial ecosystems has long outpaced the technological ability to map them with granular precision at the species level. While highly effective in common biomes, the tool faces limitations in less-studied dark biomes due to the incompleteness of reference databases. This
The 12 mg dose of retatrutide helped patients lose more than one-fifth of their body weight, setting a new benchmark for pharmacological obesity interventions. This milestone represents a paradigm shift in the treatment of chronic metabolic conditions, moving beyond simple blood sugar regulation
Phytochemicals like polyphenols and flavonoids found in jamun leaves serve as natural capping agents that prevent nanoparticle aggregation without the need for toxic stabilizers. This biological approach to nanotechnology has gained significant momentum in 2026 as industries move away from
The current practice of requiring separate scientific assessments for the same product in fifty-four different countries discourages investment and increases the cost of doing business in Africa. This structural inefficiency has long kept the continent in a state of dependency, forcing it to import
The rapid evolution of biotechnological capabilities has brought humanity to a critical juncture where the potential for life-saving discoveries is matched by the escalating complexity of biological threats. Effective biorisk governance requires a structured institutional architecture that moves
ITCurated uses cookies to personalize your experience on our website. By continuing to use this site, you agree to our Cookie Policy